Nirmal Kumar Kasinathan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nirmal Kumar Kasinathan has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Jyoti Kode
Kode Lab, Tumor Immunology & Immunotherapy Group, Advanced Center for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India
5 shared publications Madan Barkume
Anti-Cancer Drug Screening Facility (ACDSF), Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, 410210, India
4 shared publicationsNiranjali Devaraj Sivasithamparam
4 shared publications- Subramaniya Bharathi Raja
Department of Biochemistry, School of Life Sciences, Guindy Campus, University of Madras, Chennai, Tamil Nadu, India
4 shared publications - Sivachithamparam Niranjali Devaraj
Department of Biochemistry, University of Madras, Chennai, India
3 shared publications Subrata Sen
Anti-Cancer Drug Screening Facility (ACDSF), Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, 410210, India
2 shared publications
Latest Publications
- Open Access
- 3 September 2025
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 16 (5) , 101202
A traditional Cameroonian spice, Syzygium guineense curtails leukemia tumor growth through G2-M cell cycle arrest and predicted NLRP3 inflammasome pathway
- 3 September 2025
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 16 (5) , 101202
Open AccessA traditional Cameroonian spice, Syzygium guineense curtails leukemia tumor growth through G2-M cell cycle arrest and predicted NLRP3 inflammasome pathway
- Open Access
- 2 December 2024
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 15 (6) , 101015
Evaluating anticancer potentials of potentized preparations in an in-vivo xenograft model
- 2 December 2024
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 15 (6) , 101015
Open AccessEvaluating anticancer potentials of potentized preparations in an in-vivo xenograft model
- 30 June 2022
- Published by Wiley in Chemistry – A European Journal
- Vol. 28 (46) , e202201259
A Rationally Designed Bimetallic Platinum (II)‐Ferrocene Antitumor Agent Induces Non‐Apoptotic Cell Death and Exertsin VivoEfficacy
Despite phenomenal clinical success, the efficacy of platinum anticancer drugs is often compromised due to inherent and acquired drug resistant phenotypes in cancers. To circumvent this issue, we designed two heterobimetallic platinum (II)‐ferrocene hybrids that display multi‐pronged anticancer action. In cancer cells, our best compound,2, platinates DNA, produces reactive oxygen species, and has nucleus, mitochondria, and endoplasmic reticulum as potential targets. The multi‐modal mechanism of action of these hybrid agents lead to non‐apoptotic cell death induction which enables circumventing apoptosis resistance and significant improvement in platinum cross resistance profile. Finally, in addition to describing detail mechanistic insights, we also assessed its stability in plasma and demonstrate anticancer efficacy in an in vivo A2780 xenograft model. Strikingly, compared to oxaliplatin, our compound displays better tolerability, safety profile and efficacy in vivo.
- 30 June 2022
- Published by Wiley in Chemistry – A European Journal
- Vol. 28 (46) , e202201259
A Rationally Designed Bimetallic Platinum (II)‐Ferrocene Antitumor Agent Induces Non‐Apoptotic Cell Death and Exertsin VivoEfficacy
Despite phenomenal clinical success, the efficacy of platinum anticancer drugs is often compromised due to inherent and acquired drug resistant phenotypes in cancers. To circumvent this issue, we designed two heterobimetallic platinum (II)‐ferrocene hybrids that display multi‐pronged anticancer action. In cancer cells, our best compound,2, platinates DNA, produces reactive oxygen species, and has nucleus, mitochondria, and endoplasmic reticulum as potential targets. The multi‐modal mechanism of action of these hybrid agents lead to non‐apoptotic cell death induction which enables circumventing apoptosis resistance and significant improvement in platinum cross resistance profile. Finally, in addition to describing detail mechanistic insights, we also assessed its stability in plasma and demonstrate anticancer efficacy in an in vivo A2780 xenograft model. Strikingly, compared to oxaliplatin, our compound displays better tolerability, safety profile and efficacy in vivo.
- 1 December 2020
- Published by Elsevier in Bioorganic Chemistry
- Vol. 105, 104447
Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors
- 1 December 2020
- Published by Elsevier in Bioorganic Chemistry
- Vol. 105, 104447
Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors
- 1 July 2020
- Published by Elsevier in Carbohydrate Polymers
- Vol. 240, 116282
Seaweed polysaccharide derived bioaldehyde nanocomposite: Potential application in anticancer therapeutics
- 1 July 2020
- Published by Elsevier in Carbohydrate Polymers
- Vol. 240, 116282
Seaweed polysaccharide derived bioaldehyde nanocomposite: Potential application in anticancer therapeutics
- 1 February 2018
- Published by Elsevier in Journal of Functional Foods
- Vol. 41, 240-249
NF-κB/twist mediated regulation of colonic inflammation by lupeol in abating dextran sodium sulfate induced colitis in mice
- 1 February 2018
- Published by Elsevier in Journal of Functional Foods
- Vol. 41, 240-249
NF-κB/twist mediated regulation of colonic inflammation by lupeol in abating dextran sodium sulfate induced colitis in mice
- 1 August 2017
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 106, 92-106
Differential cytotoxic activity of Quercetin on colonic cancer cells depends on ROS generation through COX-2 expression
- 1 August 2017
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 106, 92-106
Differential cytotoxic activity of Quercetin on colonic cancer cells depends on ROS generation through COX-2 expression
- 1 April 2014
- Published by Elsevier in Biomedicine & Preventive Nutrition
- Vol. 4 (2) , 307-317
Aegle marmelos fruit extract abates dextran sodium sulfate induced acute colitis in mice: Repression of pro-inflammatory cytokines during colonic inflammation
- 1 April 2014
- Published by Elsevier in Biomedicine & Preventive Nutrition
- Vol. 4 (2) , 307-317
Aegle marmelos fruit extract abates dextran sodium sulfate induced acute colitis in mice: Repression of pro-inflammatory cytokines during colonic inflammation